Citation 66708

KANEDA,N: PEZZUTO,JM: SOEJARTO,DD: KINGHORN,AD: FARNSWORTH,NR: SANTISUK,T: TUCHINDA,P: UDCHACHON,J: REUTRAKUL,V:. (1991). PLANT ANTICANCER AGENTS. XLVIII. NEW CYTOTOXIC FLAVONOIDS FROM MUNTINGIA CALABURA ROOTS.. 54(1)

Citation Details

Title	PLANT ANTICANCER AGENTS. XLVIII. NEW CYTOTOXIC FLAVONOIDS FROM MUNTINGIA CALABURA ROOTS.
Authors	KANEDA,N: PEZZUTO,JM: SOEJARTO,DD: KINGHORN,AD: FARNSWORTH,NR: SANTISUK,T: TUCHINDA,P: UDCHACHON,J: REUTRAKUL,V:
Year	1991
Volume	54
Issue	1

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (1)

Muntingia calabura (ELAEOCARPACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 3'-4'-5'-7-8-PENTAMENTHOXY:	ACTIVE
19	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-HYDROXY-3'-4'-5'-7-8-PENTAMETHOXY:	ACTIVE
28	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	None
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
37	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	None
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 8-HYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
46	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	None
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 2'-8-DIHYDROXY-3'-4'-5'-7-TETRAMETHOXY:	ACTIVE
55	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	None
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVAN,2(S): 5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
64	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SINENSETIN,ISO:	None
65	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	None
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
72	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
73	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S): 5'-8-8''-TRIHYDROXY-3'-3'''-4'-4'''-5'''-7-7''-HEPTAMETHOXY:	ACTIVE
74	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	None
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
82	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-HYDROXY-3'-4'-7-8-TETRAMETHOXY:	ACTIVE
83	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	None
84	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
85	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
86	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
87	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
88	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
89	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
90	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
91	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BIFLAVAN,5-5'': (M)-(2S)-(2''S)-(P)-(2S)-(2''S)-5'-5'''-8-8''-TETRAHYDROXY-3'-3'''-4'-4'''-7-7''-HEXAMETHOXY:	ACTIVE
92	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	None
93	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
94	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
95	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
96	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
97	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
98	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
99	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE
100	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE,5'-8-DIHYDROXY-3'-4'-7-TRIMETHOXY:	ACTIVE

Citation 66708

Citation Details

Summary

Organisms and Their Experiments (1)

Muntingia calabura (ELAEOCARPACEAE)

Show SPARQL Queries (1)

Query 1